Gene 'silencer' in junk DNA prevents fatal neurological disease

Published Date: 14 Feb 2025

A team led by University of Pittsburgh School of Public Health geneticists has shown, for the first time, that a gene "silencer" that resides in junk DNA is directly sparing people from a devastating and fatal progressive ...

Read Full News

Latest News

Test Shortages Slow Fight Against Ebola in Congo, WHO Official Says

Six tons of medical supplies to fight Ebola are set to arrive in the Democratic Republic of Congo on Tuesday, ⁠but limited testing capacity was slowing the response to the...

Bird Flu Found in Polar Bear in Europe for First Time

Bird flu has been detected in a dead polar bear in the ⁠Arctic Svalbard archipelago, the first time the virus has been found in the species in ⁠Europe.

US States Reject Anti-vaccine Bills as Public Health Groups Fight MAHA

Dozens of state anti-vaccine bills backed by "Make America Healthy Again" supporters have failed after public health groups won over Republican state lawmakers, marking a...

US Health Department Withdraws Vaccine Advisory Panel Charter

The U.S. health department has withdrawn an April charter renewal for a key vaccine ⁠advisory panel that laid out new membership rules and direction, citing an...

Britain Gets Experimental Drug From Japan to Bolster Hantavirus Response

Britain has received supplies of the antiviral drug favipiravir from Japan as part of its response to a deadly hantavirus ⁠outbreak linked to the Hondius cruise liner, the...

Adult Dies of Hantavirus in Colorado, State Health Officials Say

An adult in Colorado has died after a confirmed ⁠case of hantavirus that is not linked to a recent outbreak aboard ⁠a cruise ship in the Atlantic, Colorado Department of...

Todays Updates

NP-Led Outreach Ups Cancer Screening in Rural Women Veterans

A nurse practitioner-led outreach program improves the rates of breast and cervical cancer screening among women veterans in rural areas, a retrospective study shows.

Less Mental Decline With Darolutamide vs Enzalutamide in PC

Over half of patients in a randomized trial switch from enzalutamide to darolutamide because of cognitive issues; no one switches in the opposite direction.

Todays Updates

NP-Led Outreach Ups Cancer Screening in Rural Women Veterans

A nurse practitioner-led outreach program improves the rates of breast and cervical cancer screening among women veterans in rural areas, a retrospective study shows.

Less Mental Decline With Darolutamide vs Enzalutamide in PC

Over half of patients in a randomized trial switch from enzalutamide to darolutamide because of cognitive issues; no one switches in the opposite direction.

Latest News

Six tons of medical supplies to fight Ebola are set to arrive in the Democratic Republic of Congo on Tuesday, ⁠but limited testing capacity was slowing the response to the...

Bird flu has been detected in a dead polar bear in the ⁠Arctic Svalbard archipelago, the first time the virus has been found in the species in ⁠Europe.

Dozens of state anti-vaccine bills backed by "Make America Healthy Again" supporters have failed after public health groups won over Republican state lawmakers, marking a...

The U.S. health department has withdrawn an April charter renewal for a key vaccine ⁠advisory panel that laid out new membership rules and direction, citing an...

Britain has received supplies of the antiviral drug favipiravir from Japan as part of its response to a deadly hantavirus ⁠outbreak linked to the Hondius cruise liner, the...

An adult in Colorado has died after a confirmed ⁠case of hantavirus that is not linked to a recent outbreak aboard ⁠a cruise ship in the Atlantic, Colorado Department of...

News All Time

A Child's First Flu May Set the Tone for Immunity

New research shows that a child's earliest encounter with the virus can 'imprint' the immune system, shaping how their antibodies respond to future infections.

First Lyme Vaccine in Decades Nears Approval

Positive phase 3 findings may reshape Lyme disease prevention among people with frequent tick exposure across endemic regions.

Prior Maternal Syphilis Boosts Congenital Infection Risk

A history of adequately treated syphilis before pregnancy is associated with more than a 100-fold increase in congenital syphilis risk.

US CDC Classifies Hantavirus Outbreak as 'level 3' Emergency Response, ABC News Reports

The ⁠U.S. Centers ⁠for Disease ⁠Control and ‌Prevention has classified the hantavirus ‌outbreak as 'level 3' ‌emergency ‌response, the ⁠lowest ‌level ⁠of emergency...

Telemedicine in Pediatric Care Tied to Lower Antibiotic Use

Primary care telemedicine visits for acute respiratory tract infections in children are associated with a lower rate of antibiotic prescriptions than in-person visits.

Does Mycoplasma genitalium Cause Recurrent Preterm Birth?

Mycoplasma genitalium infection shows an association with prior spontaneous preterm birth but does not increase the risk for recurrent spontaneous preterm birth.

Moderna's MRNA Flu Vaccine Outperforms Standard Shot in Late-stage Trial

Moderna's mRNA-based seasonal flu vaccine worked better than conventional flu shots in a late-stage international trial of more than 40,000 adults aged ⁠50 and older,...

CDC Says It Is Monitoring US Travelers on Cruise Ship After Hantavirus Outbreak

The United States is closely monitoring the situation with U.S. travelers on board the luxury cruise ship that was ⁠hit by a hantavirus outbreak, the Centers for Disease...

US FDA Blocked Publication of COVID, Shingles Vaccine Safety Studies

Officials at the U.S. Food and Drug Administration blocked the publication of several studies supporting the ⁠safety of widely used vaccines against COVID-19 and shingles, a...

New Surveillance Study Supports Maternal RSV Vaccine Safety

Early data keep hypertension concerns on the radar, but more robust research shows no increased risk.

Young Age, Lower BMI May Predict HIV Treatment Failure

Younger age, lower BMI for age, and lower CD4% at antiretroviral therapy initiation may predict treatment failure in children living with HIV.

California's Highest Court Leans Toward Gilead in Considering Drugmakers' 'duty to Innovate'

California's highest court on Wednesday appeared skeptical of requiring Gilead Sciences and other manufacturers of drugs that are considered safe to try developing drugs...

First Dual Flu-COVID Vaccine, mCombriax, Wins EU Approval

mCombriax demonstrates strong immunogenicity across age groups, exceeding comparator vaccines for multiple influenza strains and SARS-CoV-2 targets.

WHO Delays Pandemic Treaty Amid Pathogen-sharing Dispute

World Health Organization member states said on Friday they had extended talks on pathogen-sharing rules, ⁠casting doubt on when a pandemic treaty adopted last year can come...

Evacuations Planned as Suspected Hantavirus Outbreak Traps 150 on Ship Off Cape Verde

Medics were working on Monday to evacuate two people with symptoms of the deadly hantavirus after a suspected outbreak on a luxury cruise ship held off West Africa carrying...

The Unprecedented Rise of Scientists Fact-Checking the Feds

As trust in public health agencies erodes, researchers are finding themselves in an awkward new role — as fact-checkers of the federal government.

Recommended News For You

What is a "cancer vaccine" and is it the same as a COVID vaccine?

Trial Questions Role of Dual Immunotherapy in First-Line NSCLC

A new theranostic drug targets different cancer types.

Congress Ditched Fix to Medicare Doc Pay Cut in Skinny Budget Bill

Frontline EGFR/VEGF Inhibition Slows Advanced EGFR-Positive Lung Cancer

Alkem introduces cetuximab under the trade name Cetuxa in India.

For the treatment of paroxysmal nocturnal hemoglobinuria, the FDA has approved an oral factor B inhibitor.

Recommended Articles For You

Nipple-Sparing Mastectomy: Oncologic Safety and Patient Selection Review 

The Digital Biopsy: How Artificial Intelligence is Redefining Cancer Pathology? 

The Immunotherapeutic and Targeted Revolution in Melanoma Management – A 2025 Perspective 

Beyond the Standard: Personalized Cancer Vaccines and the Dawn of a New Era in Pediatric Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

More Positive Survival Data in Lung Cancer With Perioperative Therapy

2.

Upfront TKI for Bone-Predominant RCC Tops Single-Agent Immunotherapy

3.

Study finds 10% of pediatric blood cancers may stem from medical imaging radiation

4.

For the creation of cutting-edge targeted radionuclide therapies in oncology, Bayer and Bicycle Therapeutics work together.

5.

Pre-operative evaluation of ovarian cancer patients using DWI-MRI is helpful.

1.

Case Study: Artificial Intelligence in Early Cancer Detection

2.

Understanding Acute Intermittent Porphyria: Symptoms, Diagnosis and Treatment

3.

What is Mullerian and How Does it Affect Your Health

4.

AI in Cancer Care: Transforming Research & Treatment with Deep Learning Technologies

5.

Is p53 the Missing Puzzle Piece? Exploring Its Polymorphisms in Cervical Cancer Risk

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Should We Use DARA Up Front As First-Line Therapy in MM?

2.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV

3.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

4.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot